Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene
about
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety and Immunogenicity of a ...... ted in Alum or Polyphosphazene
@en
type
label
Safety and Immunogenicity of a ...... ted in Alum or Polyphosphazene
@en
prefLabel
Safety and Immunogenicity of a ...... ted in Alum or Polyphosphazene
@en
P2093
P2860
P50
P356
P1476
Safety and Immunogenicity of a ...... ted in Alum or Polyphosphazene
@en
P2093
Bruce L Gilliam
Georgia D Tomaras
John G McNeil
Linda L Jagodzinski
Lindsay Wieczorek
Michelle Liu
Raphaelle El-Habib
Robert J O'Connell
Robert Paris
Thomas C VanCott
P2860
P304
P356
10.1093/INFDIS/JIW059
P407
P50
P577
2016-02-11T00:00:00Z